Cas No.: | 2097713-68-1 |
Chemical Name: | OBI-3424 |
Synonyms: | 3-[5-[(1S)-1-[Bis(aziridin-1-yl)phosphoryloxy]ethyl]-2-nitrophenoxy]-N,N-dimethylbenzamide;(1R)-1-{3-[3-(Dimethylcarbamoyl)phenoxy]-4-nitrophenyl}ethyl bis(1-aziridinyl)phosphinate;OBI-3424 |
SMILES: | P(N1CC1)(N1CC1)(=O)O[C@@H](C)C1C=CC(=C(C=1)OC1C=CC=C(C(N(C)C)=O)C=1)[N+](=O)[O-] |
Formula: | C21H25N4O6P |
M.Wt: | 460.420165777206 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | AST-3424 (OBI-3424, TH-3424) is a first-in-class, novel prodrug that selectively targets cancers overexpressing the enzyme AKR1C3, OBI-3424 is a highly selective prodrug that is converted by AKR1C3 to a DNA alkylating agent; OBI-3424 is a nitro-benzene prodrug of N,N’-bisethylenephosphoramidate, demonstrates in vivo efficacy against preclinical xenograft models of pediatric T-ALL. |